LP
Schedule 13D filing
L.I.A. Pure Capital Ltd disclosed a 19.4% stake in Evogene Ltd. (EVGN)
L.I.A. Pure Capital Ltd reported owning 19.4% of Evogene Ltd. (EVGN) (3,057,488 shares) in a Schedule 13D filed Sep 11, 2026.
A 13D means the holder may push for changes at the company.
More EVGN insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.